期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Synthesis and Crystal Structure of Tianagliflozin Triacetate
1
作者 张玲钰 徐华强 +3 位作者 史永恒 王玉丽 王建武 赵桂龙 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2014年第1期85-89,共5页
The title compound tianagliflozin triacetate 1 was synthesized and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to monoclinic system (C27H31C108, Mr = 518.97), space ... The title compound tianagliflozin triacetate 1 was synthesized and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to monoclinic system (C27H31C108, Mr = 518.97), space group P21 with a = 5.3913(11), b = 16.137(2), c = 15.411(3) A, β = 94.15(3)°, V = 1337.3(5) A3, Z = 2, Dc = 1.289 g/cm3, F(000) = 548,μ = 0.190 mm1, the final R = 0.0374 and wR = 0.0809 for 3981 observed reflections (I 〉 2σ(I)). The structure of 1, triacetate of a highly potent SGLT2 inhibitor tianagliflozin, was unambiguously determined by single-crystal X-ray diffraction, which helped to confirm the desired fl configuration at the anomeric center and the position where the deoxylation occurred. The two benzene rings in the lattice are basically orthogonal to each other. There are four intermolecular hydrogen bonds in the crystal, which helps to further stabilize the crystal. 展开更多
关键词 crystal structure anti-diabetic drug sglt2 inhibitor synthesis tianagliflozin
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部